Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom
- PMID: 9579924
- DOI: 10.1111/j.1528-1157.1997.tb01220.x
Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom
Abstract
Purpose: The relationship between seizure frequency and both health care costs and quality of life (QOL) was investigated in a retrospective, cross-sectional, multicenter study in France, Germany, and the United Kingdom.
Methods: Three hundred outpatients with stable partial epilepsy were approximately evenly distributed among five seizure-frequency groups, ranging from seizure-free in the last 3 months (group 1) to daily seizures (group 5). Economic data, obtained through patient interviews and record abstraction, comprised direct medical costs, direct nonmedical costs, and indirect costs for the preceding 3 months. Total societal costs in the three countries were pooled and converted to United States dollar equivalents. QOL was assessed through a self-administered questionnaire, the Functional Status Questionnaire (FSQ).
Results: Mean total costs increased from $780 in group 1 to $2,171 in group 5 (p = 0.0001), with significant increases in each cost category as seizure frequency increased. Greater seizure frequency also significantly (p = 0.0270) correlated with lower employment rates, which ranged from 57% in group 1 to 30% in group 5. QOL declined as seizure frequency increased. Particularly affected were basic and intermediate activities of daily living (ADL), mental health, social activity, and feeling about health.
Conclusions: The study results show that higher seizure frequencies are associated with higher direct and indirect costs and with reduced QOL for patients with epilepsy.
Similar articles
-
The relationship between seizure frequency, seizure type and quality of life: findings from three European countries.Epilepsy Res. 1998 May;30(3):231-40. doi: 10.1016/s0920-1211(98)00010-2. Epilepsy Res. 1998. PMID: 9657650
-
Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany.Eur J Paediatr Neurol. 2019 May;23(3):392-403. doi: 10.1016/j.ejpn.2019.02.014. Epub 2019 Feb 28. Eur J Paediatr Neurol. 2019. PMID: 30871879
-
Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey.Epilepsy Behav. 2016 Feb;55:146-56. doi: 10.1016/j.yebeh.2015.12.018. Epub 2016 Jan 14. Epilepsy Behav. 2016. PMID: 26773686
-
[Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].Rev Neurol (Paris). 2004 Jun;160 Spec No 1:5S354-67. Rev Neurol (Paris). 2004. PMID: 15331984 Review. French.
-
The economic cost of epilepsy: a review of the literature.Epilepsia. 2002;43 Suppl 4:3-9. doi: 10.1046/j.1528-1157.43.s.4.2.x. Epilepsia. 2002. PMID: 12059995 Review.
Cited by
-
Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia.Risk Manag Healthc Policy. 2021 Jun 4;14:2385-2394. doi: 10.2147/RMHP.S289113. eCollection 2021. Risk Manag Healthc Policy. 2021. PMID: 34113193 Free PMC article.
-
The cost effectiveness of two new antiepileptic therapies in the absence of direct comparative data: a first approximation.Pharmacoeconomics. 2003;21(5):315-26. doi: 10.2165/00019053-200321050-00003. Pharmacoeconomics. 2003. PMID: 12627985
-
Emergency hospital care for adults with suspected seizures in the NHS in England 2007-2013: a cross-sectional study.BMJ Open. 2018 Oct 21;8(10):e023352. doi: 10.1136/bmjopen-2018-023352. BMJ Open. 2018. PMID: 30344177 Free PMC article.
-
Economic and health-related quality of life considerations of new therapies in Parkinson's disease.Pharmacoeconomics. 2001;19(7):729-52. doi: 10.2165/00019053-200119070-00003. Pharmacoeconomics. 2001. PMID: 11548910 Review.
-
Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults.Neurology. 2023 May 2;100(18):e1866-e1877. doi: 10.1212/WNL.0000000000207137. Epub 2023 Mar 16. Neurology. 2023. PMID: 36927880 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical